Track Lincoln Pharmaceuticals Limited — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Lincoln Pharmaceuticals Limited LINCOLN.NS · Stock Open Lincoln Pharmaceuticals Limited in new tab

597.00 INR
P/E
13.60
EPS
43.88
Yield
0.30%
P/B
1.58
ROE
12.30
Beta
0.37
Loading chart...
Key Metrics
P/E13.60
EPS43.88
Book Value378.34
Price to Book1.58
Debt/Equity0.58
% Insiders56.114%
Growth
Revenue Growth0.11%
Earnings Growth0.01%
Dividend
Dividend Yield0.30%
Annual dividends1.80 INR
Ex-Div. DateSept. 11, 2026
Payout4.10%

DCF Valuation

Tweak assumptions to recompute fair value for Lincoln Pharmaceuticals Limited (LINCOLN.NS)
Currency: INR
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Lincoln Pharmaceuticals Limited Logo Lincoln Pharmaceuticals Limited Analysis (LINCOLN.NS)

India Health Care Official Website Stock

Is Lincoln Pharmaceuticals Limited a good investment? Lincoln Pharmaceuticals Limited (LINCOLN.NS) is currently trading at 597.00 INR.

In terms of valuation, the stock trades at a P/E ratio of 13.60. This relatively low multiple may signal that Lincoln Pharmaceuticals Limited is undervalued compared to historical market norms.

For income investors, Lincoln Pharmaceuticals Limited pays a dividend yield of 0.30%. With a payout ratio of 4%, the dividend appears sustainable.

Investor FAQ

Does Lincoln Pharmaceuticals Limited pay a dividend?

Yes, it pays an annual dividend of 1.80 INR (0.30% yield).

What asset class is Lincoln Pharmaceuticals Limited?

Lincoln Pharmaceuticals Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. Lincoln Pharmaceuticals Limited was incorporated in 1979 and is based in Ahmedabad, India.

Exchange Ticker
NSI (India) LINCOLN.NS
Trades
Dividend Yield
0.30%
Annual Dividends
1.80INR
Next Ex. Div Date
Sept. 11, 2026
Payout Ratio
4.10%
Dividend History paid per year (INR)
Historical Dividends
Year Total Dividends
▸2026
1.80 INR
Oct. 30, 2026 1.8000
▸2025
1.80 INR
Oct. 30, 2025 1.8000
▸2024
1.80 INR
Oct. 7, 2024 1.8000
▸2023
1.50 INR
Oct. 30, 2023 1.5000
▸2022
1.50 INR
Oct. 30, 2022 1.5000
▸2021
1.50 INR
Oct. 30, 2021 1.5000
▸2020
1.50 INR
March 28, 2020 1.5000
▸2019
1.50 INR
Oct. 30, 2019 1.5000
▸2018
1.50 INR
Oct. 29, 2018 1.5000
▸2017
1.20 INR
Oct. 29, 2017 1.2000
▸2016
1.00 INR
Oct. 30, 2016 1.0000
Upcoming Dividends
Name Payment Date Status Amount
Lincoln Pharmaceuticals Limited Oct 30, 2026 Upcoming 1.8 INR
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion